Showing results (231-240 of 1,232) with videos related to
Sort By:
Pageof 124
Cells|September 23, 2020
Genetic Variation in CNS Myelination and Functional Brain Connectivity in Recombinant Inbred MiceAndrea Goudriaan, Maarten Loos, Sabine Spijker, et al.Regulatory Toxicology and Pharmacology : RTP|February 23, 2020
Towards the development of an omics data analysis frameworkMarcha Verheijen, Weida Tong, Leming Shi, et al.Nanotechnology|February 14, 2015
Sub-nanometer dimensions control of core/shell nanoparticles prepared by atomic layer depositionM J Weber, M A Verheijen, A A Bol, et al.Ecology and Evolution|September 11, 2023
Lesser Prairie-chicken incubation behavior and nest success most influenced by nest vegetation structureJacquelyn M Gehrt, Daniel S Sullins, Bram H F Verheijen, et al.Journal of Human Evolution|December 24, 2022
Early evidence for bear exploitation during MIS 9 from the site of Schöningen 12 (Germany)Ivo Verheijen, Britt M Starkovich, Jordi Serangeli, et al.Seminars in Cancer Biology|April 15, 1999
CA 125: fundamental and clinical aspectsR H Verheijen, S von Mensdorff-Pouilly, G J van Kamp, et al.Pharmaceutical Research|April 17, 2001
Inhibition of angiotensin II-induced inositol phosphate production by triacid nonpeptide antagonists in CHO cells expressing human AT1 receptorsP M Vanderheyden, I Verheijen, F L Fierens, et al.Biochimica Et Biophysica Acta|September 28, 1984
Evidence for the presence of two different fibrinolytic inhibitors in human endothelial cell conditioned mediumE D Sprengers, J H Verheijen, V W Van Hinsbergh, et al.Thrombosis and Haemostasis|December 29, 1984
Fibrinolytic activators and inhibitors in terminal renal insufficiency and in anephric patientsE J Brommer, I Schicht, G Wijngaards, et al.Thrombosis Research|October 1, 1983
Differences in effects of fibrin(ogen) fragments on the activation of 1-glu-plasminogen and 442-val-plasminogen by tissue-type plasminogen activatorJ H Verheijen, W Nieuwenhuizen, D W Traas, et al.Pageof 124